These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 18354200)

  • 1. TLR-activated B cells suppress T cell-mediated autoimmunity.
    Lampropoulou V; Hoehlig K; Roch T; Neves P; Calderón Gómez E; Sweenie CH; Hao Y; Freitas AA; Steinhoff U; Anderton SM; Fillatreau S
    J Immunol; 2008 Apr; 180(7):4763-73. PubMed ID: 18354200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-10 mediates resistance to adoptive transfer experimental autoimmune encephalomyelitis in MyD88(-/-) mice.
    Cohen SJ; Cohen IR; Nussbaum G
    J Immunol; 2010 Jan; 184(1):212-21. PubMed ID: 19949074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals.
    Yanaba K; Bouaziz JD; Matsushita T; Tsubata T; Tedder TF
    J Immunol; 2009 Jun; 182(12):7459-72. PubMed ID: 19494269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement for MyD88 signaling in B cells and dendritic cells for germinal center anti-nuclear antibody production in Lyn-deficient mice.
    Hua Z; Gross AJ; Lamagna C; Ramos-Hernández N; Scapini P; Ji M; Shao H; Lowell CA; Hou B; DeFranco AL
    J Immunol; 2014 Feb; 192(3):875-85. PubMed ID: 24379120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity.
    Kim WS; Kim H; Kwon KW; Im SH; Lee BR; Ha SJ; Shin SJ
    Oncotarget; 2016 Jun; 7(23):33765-82. PubMed ID: 27172902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of TLR2, TRL3, TRL4, and TRL9 signaling in the pathogenesis of autoimmune disease in a retinal autoimmunity model.
    Fang J; Fang D; Silver PB; Wen F; Li B; Ren X; Lin Q; Caspi RR; Su SB
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3092-9. PubMed ID: 20107166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus.
    Teichmann LL; Schenten D; Medzhitov R; Kashgarian M; Shlomchik MJ
    Immunity; 2013 Mar; 38(3):528-40. PubMed ID: 23499488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis.
    Marta M; Andersson A; Isaksson M; Kämpe O; Lobell A
    Eur J Immunol; 2008 Feb; 38(2):565-75. PubMed ID: 18203139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacillus-derived poly-γ-glutamic acid reciprocally regulates the differentiation of T helper 17 and regulatory T cells and attenuates experimental autoimmune encephalomyelitis.
    Lee K; Hwang S; Paik DJ; Kim WK; Kim JM; Youn J
    Clin Exp Immunol; 2012 Oct; 170(1):66-76. PubMed ID: 22943202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B Cell-Intrinsic MyD88 Signaling Promotes Initial Cell Proliferation and Differentiation To Enhance the Germinal Center Response to a Virus-like Particle.
    Tian M; Hua Z; Hong S; Zhang Z; Liu C; Lin L; Chen J; Zhang W; Zhou X; Zhang F; DeFranco AL; Hou B
    J Immunol; 2018 Feb; 200(3):937-948. PubMed ID: 29282308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of autoimmune encephalomyelitis by toll-like receptors.
    Marta M; Meier UC; Lobell A
    Autoimmun Rev; 2009 May; 8(6):506-9. PubMed ID: 19211042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptors in multiple sclerosis mouse experimental models.
    Marta M
    Ann N Y Acad Sci; 2009 Sep; 1173():458-62. PubMed ID: 19758186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIF is a critical negative regulator of TLR agonist mediated activation of dendritic cells in vivo.
    Seregin SS; Aldhamen YA; Appledorn DM; Aylsworth CF; Godbehere S; Liu CJ; Quiroga D; Amalfitano A
    PLoS One; 2011; 6(7):e22064. PubMed ID: 21760953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE.
    Isaksson M; Ardesjö B; Rönnblom L; Kämpe O; Lassmann H; Eloranta ML; Lobell A
    Eur J Immunol; 2009 Oct; 39(10):2925-35. PubMed ID: 19637225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MyD88 is essential to sustain mTOR activation necessary to promote T helper 17 cell proliferation by linking IL-1 and IL-23 signaling.
    Chang J; Burkett PR; Borges CM; Kuchroo VK; Turka LA; Chang CH
    Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2270-5. PubMed ID: 23341605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic benefits of regulating inflammation in autoimmunity.
    Nikoopour E; Schwartz JA; Singh B
    Inflamm Allergy Drug Targets; 2008 Sep; 7(3):203-10. PubMed ID: 18782028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmunity stimulated by adoptively transferred dendritic cells is initiated by both alphabeta and gammadelta T cells but does not require MyD88 signaling.
    Martin DA; Zhang K; Kenkel J; Hughes G; Clark E; Davidson A; Elkon KB
    J Immunol; 2007 Nov; 179(9):5819-28. PubMed ID: 17947655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The innate immune adaptor MyD88 is dispensable for spontaneous autoimmune demyelination in a mouse model of multiple sclerosis.
    Wexler AG; Frielle C; Berry G; Budgeon LR; Baccon J; Christensen ND; Waldner H
    J Neuroimmunol; 2013 Feb; 255(1-2):60-9. PubMed ID: 23269203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of toll-like receptors in spontaneous commensal-dependent colitis.
    Rakoff-Nahoum S; Hao L; Medzhitov R
    Immunity; 2006 Aug; 25(2):319-29. PubMed ID: 16879997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential TLR activation of murine mesenchymal stem cells generates distinct immunomodulatory effects in EAE.
    Vega-Letter AM; Kurte M; Fernández-O'Ryan C; Gauthier-Abeliuk M; Fuenzalida P; Moya-Uribe I; Altamirano C; Figueroa F; Irarrázabal C; Carrión F
    Stem Cell Res Ther; 2016 Oct; 7(1):150. PubMed ID: 27724984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.